FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Device, Hemostasis, Vascular
PMA: P120016
·
Supplement: S034
·
Decision Jan 3, 2024
Classifications
1
FEI Numbers
33
Registration Numbers
33
Basic Information
- Device Name
- Device, Hemostasis, Vascular
- Trade Name
- Cardiva VASCADE Family
- PMA Number
- P120016
- Supplement Number
- S034
- Device Class
- FDA Class 3
- Product Code
- MGB
- Generic Name
- Device, hemostasis, vascular
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- January 3, 2024
- Date Received
- December 5, 2023
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
an additional controlled environment room at the approved Guaymas facility (Sonora, Mexico) for the Cardiva Vascade Family
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MGB | Device, Hemostasis, Vascular | FDA class 3 | Unknown |